Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Gastroenterology
•
Disorders of the Colon
Do you continue antiplatelet/anticoagulant therapy in patients with hemodynamically stable diverticular bleeding to improve localization and treatment of source of bleeding?
Related Questions
Has your institution and/or antimicrobial stewardship program incorporated a selective antibiotic approach to treatment of left-sided uncomplicated diverticulitis in immunocompetent patients?
Under what circumstances would you recommend early fecal microbiota transplantation over antibiotic treatment or bezlotoxumab in a patient with recurrent C. difficile infection?
What is your approach to treatment of patients with fulminant C difficile infection who required ileostomy creation or colectomy?
Do you recommend, based on current evidence, avoiding antimotility agents in patients with non-fulminant C. difficile infection who have no evidence of ileus?
What is your approach to duration of fidaxomicin in a patient receiving treatment for first C difficile infection while also receiving concurrent antibiotics for an infection?
How do you approach the treatment of microscopic colitis?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
In which patients do you recommend endoscopic bariatric procedures (such as endoscopic sleeve gastroplasty) instead of laparoscopic bariatric surgery?
Do you feel there is any difference between performing an ERCP with an EDGE together in a single session or separately in two sessions in a patient with Roux-en-Y anatomy?
Would you offer chemoRT to a colon cancer case with a resected polyp with positive margins if the patient wishes to avoid surgery?
